Key Takeaways Novavax shares more than doubled in intraday trading Friday as it announced a $1.2 billion deal to license…
Read More »vaccines
COVID-19 vaccination rates remain low in many African countries, often because providing access to vaccines is difficult in remote areas.…
Read More »Topline There is no evidence to suggest COVID vaccines could cause sudden cardiac death and other heart problems in young…
Read More »Jackyenjoyphotography/Getty Images Jackyenjoyphotography/Getty Images According to the Centers for Disease Control and Prevention, about one in four adults has a…
Read More »A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19.…
Read More »The tears and screaming, as upsetting as they are, are well worth the effort. A simple prick of the skin…
Read More »mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in…
Read More »Landmark study contradicts misinformation about brain development and conditions like autism in children. The COVID vaccine is safe to administer…
Read More »The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of…
Read More »Merck & Co. Inc. on Thursday reported fourth-quarter earnings and sales that beat analysts’ expectations, powered by strong growth in…
Read More »